The Effects of Transcutaneous Electrical Nerve Stimulation in Patients With Total Knee Replacement
NCT ID: NCT05115565
Last Updated: 2021-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2021-11-15
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TENS is an easy-to-apply, inexpensive, noninvasive, noninvasive method that uses electrical current to activate nerves with therapeutic effects in the treatment of acute and chronic pain. It is also seen as a promising practice in patients undergoing total knee replacement surgery by the American Society of Regional Anesthesia and Pain Medicine (ASRA) and the European Society of Regional Anaesthesia and Pain Therapy (ESRA).
The study was planned as a randomized controlled study to examine the effect of TENS on acute pain, functionality and quality of life after TDP. The hypotheses of the study; H1a- TENS applied after TDP positively affects the level of pain in patients. H1b- TENS applied after TDP affects the improvement in functional status in patients.
H1c- TENS applied after TDP reduces the analgesia consumption of patients. H1d- TENS applied after TDP positively affects the quality of life of patients. Type of Study: Randomized controlled trial. Method: 52 patients (26 controls, 26 interventions) who underwent total knee replacement surgery will be randomized and divided into two groups as intervention and control groups. TENS will be applied to the intervention group in addition to the routine treatment and care in the clinic, on the other hand, no intervention will be made to the control group other than routine treatment and care. Data will be collected with Patient identification form, Pain Evaluation Form, Visual Analogue Scale (VAS), Analgesic Drug Tracking Form, Joint Range of Motion (ROM) Follow-up Form, Western Ontario and McMaster Universities Arthritis Index (WOMAC), Quality of Life Scale (SF-36).
While evaluating the data, it is planned to be analyzed as randomized.It is planned to use multiple completion methods when there are missing data.Statistical analyzes are planned to be evaluated with the SPSS-24 package program. It is planned to use frequency charts and descriptive statistics in order to interpret the data, parametric techniques for normal distributions and non-parametric techniques for non-normal distributions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
When the patients are admitted to the clinic, the patient identification form and the SF-36 Quality of Life Scale will be filled by face-to-face interview method. On the morning of the operation, before the operation, the GCS, EHA and WOMAC index will be filled. After the operation, the pain during rest and movement (24., 48., 72., 96. hours and 15. days) will be evaluated with VAS. The total amount of analgesics used by the patients will be recorded by looking at the nurse observation form records where the nurses recorded the drugs they administered at the 24th, 48th, 72nd, and 96th hours after the surgery, and by asking the patients on the 15th day after discharge. The WOMAC Index will be re-administered at discharge and on the 15th day, and the VCS, ROM, and the SF-36 Quality of Life Scale on the 15th day.
No interventions assigned to this group
Intervention group
Unlike the control group, the patients in the intervention group will be informed about TENS and the application will be made. The electrodes of TENS will be placed 2 cm below and 2 cm above the incision site. TENS settings Frequency: 100 Hz; Pulse width (duration): 150 μs; Flow Intensity (Amplitude): By adjusting it to be 30 mA, TENS will be applied 3 times a day (09.00, 13.00, 17.00) for 20 minutes during the time the patients stay in the clinic (3 days).It is planned to start the TENS application the day after the surgery.
TENS (Transcutaneous Electrical Nerve Stimulation) Application
Conventional (traditional) TENS will be applied to the patients. The frequency will be 100 Hz, the pulse width (time) will be 150 μs, the current intensity (amplitude) will be 30 mA. In addition to routine care and treatment, TENS will be applied to intervention group patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS (Transcutaneous Electrical Nerve Stimulation) Application
Conventional (traditional) TENS will be applied to the patients. The frequency will be 100 Hz, the pulse width (time) will be 150 μs, the current intensity (amplitude) will be 30 mA. In addition to routine care and treatment, TENS will be applied to intervention group patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having unilateral prosthesis surgery,
* Not having a pacemaker or arrhythmia,
* Not having neurological deficit,
* Absence of sensory loss, paresthesia or hyporeflexia,
* Not having local or systemic infection,
* Not using opioids or TENS before surgery,
* Not having history of chronic pain,
* Not having history of alcohol or drug use,
* Not having a psychiatric history,
* Not having been done to apply epidural analgesia in the postoperative period,
* Not having serious complications after surgery,
* Not having a history of neurological disease (SVO, epilepsy, dementia, etc.),
* Not having active tumor or cancer,
* Not having fractures or dislocations,
* Absence of signs of venous thromboembolism,
* Having an ASA score of I and II,
* Agree to participate in the research and
* Know how to read and write
Exclusion Criteria
* Having double-sided prosthesis surgery,
* Having a pacemaker and arrhythmia,
* Having a neurological deficit,
* Having loss of sensation, paresthesia or hyporeflexia,
* Having local or systemic infection,
* Having been used opioids and or TENS before surgery,
* Having a history of chronic pain,
* Having a history of alcohol or drug use,
* Having a psychiatric history,
* Administering epidural analgesia in the postoperative period,
* Developing serious complications after surgery,
* Having a history of neurological disease (SVO, epilepsy, dementia, etc.),
* Having an active tumor or cancer,
* Having fracture or dislocation,
* Having symptoms of venous thrombosis,
* Not having ASA score I or II,
* Not agreeing to participate in the study,
* Illiteracy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bozok University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nilgun Ozbas
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nilgün Özbaş, Assist. Prof
Role: PRINCIPAL_INVESTIGATOR
Bozok University
Emre Ersoy, Assist. Prof
Role: STUDY_CHAIR
Bozok University
Hacı Ali Olçar, Doctor
Role: STUDY_CHAIR
Bozok University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yozgat Bozok University Research and Application Hospital
Yozgat, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nilgün Özbaş, Assist Prof
Role: primary
Murat Korkmaz, Professor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-KAEK-189_2021.09.22_05
Identifier Type: -
Identifier Source: org_study_id